Rezolute, Inc. (RZLT)
Nasdaq: RZLT · Pharmaceutical Preparations · Redwood City, CA · filing with the SEC since 2011
Who owns Rezolute, Inc.
As filed with the SECHolders of 5% or more
4
RA Capital Management, L.P. holds 9.9% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G filed Dec 18, 2025 says.
Directors and officers
10
report now, of 20 people on the record since 2013. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
RA Capital Management, L.P.
SCHEDULE 13G · filed Dec 18, 2025 · Common Stock, par value $0.001 per share
Opaleye Management Inc.
SCHEDULE 13G/A · filed May 11, 2026 · Common Stock · 5.3% in Dec 19, 2025
Dellora Investments LP
SCHEDULE 13G · filed Aug 12, 2026 · Common Stock, $0.001 par value per share
Blackrock, Inc.
SCHEDULE 13G · filed Oct 17, 2025 · Common Stock
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 8.6% in Nov 14, 2024
Balyasny Asset Management L.P.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock · reported falling below 5%, from 5.28% in May 15, 2026
Fmr LLC
SCHEDULE 13G/A · filed Jan 8, 2026 · COMMON STOCK · reported falling below 5%, from 15% in Aug 6, 2025
Bank of America Corporation
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Stock · reported falling below 5%, from 6.5% in Feb 11, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 5.16% in Jan 30, 2026
Invus Public Equities, L.P.
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, $0.001 par value per share · reported falling below 5%, from 5.4% in Sep 22, 2025
What RZLT reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Sep 24, 2026.
Insider tradesForm 4
0sales
9purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Oct 23, 2025 to Oct 23, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 23, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 22 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Evans Daron | CFO | 0 | $0 | 0 | 4 | $100,000 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | 0 | $0 | 0 | 2 | $0 |
| Elam Nevan C | CEO | 0 | $0 | 0 | 1 | $100,000 |
| Roberts Brian Kenneth | Chief Medical Officer | 0 | $0 | 0 | 1 | $0 |
| Hogenhuis Wladimir | director | 0 | $0 | 0 | 1 | $0 |